stockrow
Friday 6 November 2026
Export VREX’s income statement to Excel — free account
VAREX IMAGING
VREX Healthcare Medical Devices
VAREX IMAGING’s revenue for fiscal 2025 (year ended September 2025) was $844.6 million, up 4.14% from fiscal 2024.
- Revenue
- +3.69%
- EPS
- +117.2%
- Free cash flow
- +757.1%
- Total debt
- −5.55%
Quarter to June 2026, against a year earlier
18.44
0.00
0.00%
Follow VREX
Alert me
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 4 | 6 | 3 | 8 | 6 | 5 | 3 | 6 |
P/E ratio |
13.13 | 24.83 | 38.23 | 66.37 | 0.00 | 62.67 | 27.45 | 15.50 | 0.00 | 0.00 |
Altman Z-Score |
— | 2.54 | 2.56 | 2.41 | 1.39 | 2.39 | 2.28 | 2.21 | 1.71 | 1.66 |
P/S ratio |
1.67 | 1.84 | 1.37 | 1.40 | 0.67 | 1.35 | 0.98 | 0.84 | 0.60 | 0.61 |
Altman Z″-Score (non-manufacturers) |
12.64 | 3.42 | 3.34 | 2.99 | 2.65 | 3.55 | 4.00 | 4.24 | 3.66 | 3.33 |
P/FCF ratio |
16.48 | 23.41 | 16.30 | 20.93 | 0.00 | 14.30 | 0.00 | 8.55 | 23.84 | 27.31 |
Beneish M-Score |
(2.57) | (3.28) | (2.74) | (2.76) | (2.80) | (2.66) | (2.31) | (2.73) | (2.91) | (3.13) |
P/Operating CF |
54.83 | 83.62 | 57.18 | 47.61 | (41.83) | 21.90 | 49.20 | 15.91 | 18.78 | 64.98 |
P/B ratio |
1.90 | 3.40 | 2.47 | 2.43 | 1.06 | 2.23 | 1.54 | 1.29 | 0.90 | 1.06 |
Price to Tangible BV |
2.20 | 28.12 | 9.54 | 15.33 | 4.69 | 7.22 | 3.68 | 2.78 | 2.06 | 1.87 |
EV/Sales |
1.58 | 2.42 | 1.80 | 1.86 | 1.15 | 1.71 | 1.36 | 1.12 | 0.90 | 0.86 |
EV/EBITDA |
8.27 | 14.95 | 15.17 | 15.80 | 61.92 | 11.52 | 8.79 | 8.84 | 11.05 | 7.56 |
EV/Operating CF |
11.44 | 22.45 | 16.36 | 20.24 | 64.26 | 15.10 | 69.02 | 9.21 | 15.42 | 17.40 |
EV/FCF |
15.63 | 30.70 | 21.51 | 27.94 | (82.35) | 18.04 | (265.08) | 11.38 | 35.75 | 38.60 |
Quick Ratio |
2.04 | 1.63 | 1.35 | 0.98 | 1.40 | 1.80 | 1.52 | 2.20 | 1.83 | 1.67 |
Current Ratio |
4.63 | 3.26 | 3.01 | 2.50 | 3.25 | 3.33 | 3.52 | 4.04 | 3.32 | 3.43 |
Net Debt/EBITDA |
(0.29) | 3.55 | 3.67 | 3.97 | 25.89 | 2.39 | 2.45 | 2.20 | 3.68 | 2.21 |
Debt/Assets |
0.00% | 46.52% | 39.46% | 38.03% | 39.96% | 37.86% | 34.99% | 35.42% | 36.54% | 33.19% |
Debt/Equity |
0.00 | 1.28 | 0.91 | 0.88 | 0.98 | 0.88 | 0.76 | 0.76 | 0.82 | 0.76 |
Asset Turnover |
1.03 | 0.84 | 0.76 | 0.77 | 0.68 | 0.72 | 0.74 | 0.73 | 0.66 | 0.73 |
Operating CF/Net income |
1.08 | 1.46 | 3.10 | 4.64 | (0.23) | 5.32 | 0.56 | 2.29 | (0.97) | (0.59) |
Capex/Depreciation |
(1.89) | (0.69) | (0.43) | (0.43) | (0.50) | (0.32) | (0.48) | (0.58) | (0.79) | (0.18) |
Interest Coverage |
57.42 | 6.80 | 2.05 | 2.17 | (1.07) | 1.76 | 2.22 | 2.63 | 1.06 | (0.78) |
| 13.41% | 11.40% | 6.81% | 3.54% | (12.67%) | 3.62% | 5.81% | 8.41% | (8.68%) | (13.65%) | |
| 11.36% | 6.21% | 2.71% | 1.53% | (5.32%) | 1.52% | 2.60% | 3.89% | (3.96%) | (6.06%) | |
ROIC |
13.93% | 6.71% | 3.63% | 3.51% | (2.57%) | 5.89% | 6.32% | 5.81% | 2.55% | (2.49%) |
Return on Tangible Assets |
17.52% | 10.49% | 6.10% | 3.82% | (11.43%) | 3.30% | 5.24% | 7.42% | (8.03%) | (11.48%) |
Average Days of Receivables |
71.93 | 85.54 | 72.68 | 65.93 | 61.20 | 69.29 | 73.60 | 66.84 | 70.97 | 67.68 |
Research and Development Expense of Revenue |
8.63% | 9.64% | 10.73% | 10.01% | 10.69% | 8.79% | 8.96% | 9.49% | 10.73% | 10.79% |
Selling, General and Administrative Expense of Revenue |
13.84% | 14.68% | 15.96% | 16.41% | 19.26% | 15.34% | 13.77% | 14.37% | 16.99% | 15.78% |
Intangible Assets out of Total Assets |
0.15 | 0.32 | 0.32 | 0.36 | 0.32 | 0.30 | 0.27 | 0.25 | 0.25 | 0.19 |
Share Based Compensation of Revenue |
1.53% | 1.20% | 1.29% | 1.50% | 1.81% | 1.70% | 1.63% | 1.51% | 1.89% | 1.78% |
Graham Net Nets |
0.27 | (0.13) | (0.10) | (0.14) | (0.31) | (0.09) | (0.03) | (0.01) | (0.04) | 0.04 |
Graham Number |
0.00 | 17.69 | 13.62 | 10.65 | 0.00 | 11.31 | 15.43 | 19.73 | 0.00 | 0.00 |
Earnings Yield |
7.62% | 4.03% | 2.62% | 1.51% | (11.56%) | 1.60% | 3.64% | 6.45% | (9.82%) | (13.71%) |
Free Cash Flow Yield |
6.07% | 4.27% | 6.14% | 4.78% | (2.09%) | 6.99% | (0.52%) | 11.70% | 4.19% | 3.66% |
Revenue per Share |
16.58 | 18.57 | 20.41 | 20.43 | 19.03 | 20.82 | 21.59 | 22.17 | 19.88 | 20.40 |
Operating CF per Share |
1.98 | 2.00 | 2.25 | 1.88 | 0.34 | 2.36 | 0.42 | 2.69 | 1.16 | 1.01 |
Capex per Share |
(0.77) | (0.54) | (0.54) | (0.52) | (0.61) | (0.38) | (0.54) | (0.51) | (0.66) | (0.55) |
Free Cash Flow per Share |
1.21 | 1.46 | 1.71 | 1.36 | (0.27) | 1.97 | (0.11) | 2.18 | 0.50 | 0.45 |
Cash per Share |
0.98 | 2.22 | 1.37 | 0.78 | 2.59 | 3.68 | 2.25 | 4.81 | 4.91 | 3.75 |
Shareholders Equity per Share |
14.06 | 10.08 | 11.30 | 11.73 | 12.01 | 12.63 | 13.74 | 14.42 | 13.31 | 11.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
14.06 | 10.08 | 11.30 | 11.73 | 12.01 | 12.63 | 13.74 | 14.42 | 13.31 | 11.75 |
Free Cash Flow |
45.30 | 55.00 | 64.90 | 52.10 | (10.30) | 77.50 | (4.40) | 87.70 | 20.40 | 18.80 |
Working Capital |
282.10 | 343.50 | 306.10 | 263.30 | 361.40 | 387.60 | 436.80 | 495.50 | 454.00 | 454.60 |
Capital Expenditures |
(28.90) | (20.20) | (20.40) | (19.80) | (23.50) | (15.10) | (21.30) | (20.70) | (26.90) | (22.90) |
Net Current Asset Value |
263.50 | (165.80) | (101.50) | (152.30) | (151.70) | (96.80) | (27.80) | (10.30) | (20.50) | 21.00 |
EV/EBIT |
9.50 | 20.17 | 31.36 | 31.85 | 0.00 | 18.87 | 13.22 | 12.95 | 22.72 | 0.00 |
Capex to Sales |
0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
Price to Operating Income |
10.02 | 15.39 | 23.77 | 23.86 | 0.00 | 14.96 | 9.54 | 9.72 | 15.15 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.20 | 0.33 | 0.33 | 0.33 | 0.34 | 0.31 | 0.25 | 0.22 | 0.78 |
Cash ROIC |
8.05% | 5.81% | 7.46% | 5.97% | (1.01%) | 7.21% | (0.42%) | 7.20% | 1.72% | 1.86% |
Accounts Receivable Turnover |
5.17 | 4.89 | 4.87 | 5.29 | 5.58 | 5.86 | 5.23 | 5.30 | 5.05 | 5.37 |
Accounts Payable Turnover |
8.12 | 8.82 | 8.30 | 8.42 | 8.36 | 8.30 | 8.41 | 8.44 | 8.95 | 8.59 |
Inventory Turnover |
2.00 | 2.06 | 2.21 | 2.17 | 2.11 | 2.20 | 2.18 | 2.08 | 2.04 | 1.96 |
Average Days of Payables |
41.14 | 48.35 | 46.58 | 40.55 | 48.55 | 39.26 | 49.56 | 39.16 | 38.93 | 46.04 |
Days of Inventory on Hand |
193.84 | 192.52 | 165.18 | 172.92 | 181.07 | 150.11 | 192.17 | 167.94 | 174.43 | 197.22 |
Average Receivables |
120.00 | 142.90 | 158.80 | 147.50 | 132.40 | 139.55 | 164.30 | 168.45 | 160.65 | 157.15 |
Average Payables |
45.80 | 50.40 | 62.60 | 62.25 | 65.55 | 65.85 | 68.50 | 71.45 | 61.90 | 64.50 |
Average Inventory |
186.15 | 215.95 | 234.80 | 241.65 | 260.05 | 248.35 | 264.00 | 290.35 | 271.15 | 282.10 |
Average Assets |
603.00 | 831.25 | 1,014.00 | 1,013.40 | 1,089.20 | 1,143.50 | 1,165.95 | 1,217.00 | 1,231.60 | 1,160.50 |
Average Common Equity |
510.80 | 452.50 | 403.65 | 438.25 | 457.00 | 481.15 | 521.60 | 563.85 | 562.10 | 514.90 |
Columns are period end dates · fundamentals updated 25 Oct 2026